| Product Code: ETC6652147 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada COVID-19 Molecular Diagnostics Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada COVID-19 Molecular Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Canada COVID-19 Molecular Diagnostics Market - Industry Life Cycle |
3.4 Canada COVID-19 Molecular Diagnostics Market - Porter's Five Forces |
3.5 Canada COVID-19 Molecular Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Canada COVID-19 Molecular Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Canada COVID-19 Molecular Diagnostics Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Canada COVID-19 Molecular Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for accurate and rapid diagnostic testing due to rising Covid-19 cases in Canada |
4.2.2 Government initiatives to expand testing capabilities and improve healthcare infrastructure |
4.2.3 Technological advancements in molecular diagnostics leading to more efficient testing methods |
4.3 Market Restraints |
4.3.1 Supply chain disruptions affecting the availability of testing kits and reagents |
4.3.2 Regulatory challenges and approval processes for new diagnostic technologies |
4.3.3 Economic constraints impacting healthcare budgets and investment in diagnostic testing |
5 Canada COVID-19 Molecular Diagnostics Market Trends |
6 Canada COVID-19 Molecular Diagnostics Market, By Types |
6.1 Canada COVID-19 Molecular Diagnostics Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Canada COVID-19 Molecular Diagnostics Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Canada COVID-19 Molecular Diagnostics Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.4 Canada COVID-19 Molecular Diagnostics Market Revenues & Volume, By Reagents & Kits, 2021- 2031F |
6.2 Canada COVID-19 Molecular Diagnostics Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Canada COVID-19 Molecular Diagnostics Market Revenues & Volume, By PCR, 2021- 2031F |
6.2.3 Canada COVID-19 Molecular Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Canada COVID-19 Molecular Diagnostics Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Canada COVID-19 Molecular Diagnostics Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.3.3 Canada COVID-19 Molecular Diagnostics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.4 Canada COVID-19 Molecular Diagnostics Market Revenues & Volume, By Diagnostic Centers and Clinics, 2021- 2031F |
6.3.5 Canada COVID-19 Molecular Diagnostics Market Revenues & Volume, By Research Institutes, 2021- 2031F |
7 Canada COVID-19 Molecular Diagnostics Market Import-Export Trade Statistics |
7.1 Canada COVID-19 Molecular Diagnostics Market Export to Major Countries |
7.2 Canada COVID-19 Molecular Diagnostics Market Imports from Major Countries |
8 Canada COVID-19 Molecular Diagnostics Market Key Performance Indicators |
8.1 Average turnaround time for test results |
8.2 Adoption rate of new molecular diagnostic technologies |
8.3 Percentage of population tested regularly for Covid-19 |
8.4 Rate of accuracy in test results |
8.5 Utilization rate of testing capacity |
9 Canada COVID-19 Molecular Diagnostics Market - Opportunity Assessment |
9.1 Canada COVID-19 Molecular Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Canada COVID-19 Molecular Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Canada COVID-19 Molecular Diagnostics Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Canada COVID-19 Molecular Diagnostics Market - Competitive Landscape |
10.1 Canada COVID-19 Molecular Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Canada COVID-19 Molecular Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here